Data updated: Mar 10, 2026
SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE
PREDNISOLONE SODIUM PHOSPHATE
Approved 1993-05-27
2
Indications
--
Phase 3 Trials
32
Years on Market
Details
- Status
- Discontinued
- First Approved
- 1993-05-27
- Routes
- OPHTHALMIC
- Dosage Forms
- SOLUTION/DROPS
Companies
Website: ↗
SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE Approval History
Loading approval history...
What SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE Treats
2 FDA approvalsOriginally approved for its first indication in 1993 . Covers 2 distinct patient populations.
- Other (2)
Other
(2 approvals)- • Approved indication (May 1993)
- • Approved indication (Dec 1995)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.